Contribution of new techniques for the diagnosis of congenital toxoplasmosis

Clinical Laboratory

Volumn 47, Issue 3-4, 2001, Pages 135-141

  Robert Gangneux, F ^a  

^a NONE   (France)

Author keywords

Congenital toxoplasmosis; Diagnosis; IgG avidity; PCR; Serology; Western blot

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RIBOSOME DNA; RIBOSOME RNA; URACIL DNA GLYCOSYLTRANSFERASE;

AMNION FLUID ANALYSIS; ANTIBODY DETECTION; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FOLLOW UP; GENE TARGETING; HUMAN; PERINATAL PERIOD; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SEROLOGY; UMBILICAL CORD BLOOD; WESTERN BLOTTING;

FEMALE; FRANCE; HUMANS; INFANT, NEWBORN; LABORATORY TECHNIQUES AND PROCEDURES; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL DIAGNOSIS; SEROEPIDEMIOLOGIC STUDIES; TOXOPLASMOSIS, CONGENITAL;

PROTOZOA;

EID: 0035083173     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Congenital and maternal toxoplasmosis: A review of 300 congenital cases
2. Results of 20 years follow-up of congenital toxoplasmosis
3. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection
4. La toxoplasmose chez la femme enceinte en France en 1995
5. Recent rubella virus infection indicated by a low avidity of specific IgG
6. Toxoplasmosis acquired during pregnancy: Improve serodiagnosis based on avidity of IgG
7. Interêt de l'étude de l'avidité des IgG pour le diagnostic de la toxoplasmose
8. Variations in affinity of antibodies during the immune response
9. The diagnosis of toxoplasmosis using IgG avidity
10. Apport de l'avidité des anticorps dans la datation d'une séroconversion toxoplasmique
11. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidiy
12. Lack of utility of specific IgG antibody avidity for the serodiagnosis of reactivated toxoplasmosis in immunocompromised patients
13. Recent primary Toxoplasma infection indicated by a low avidity of specific IgG
14. Detection of specific IgE in patients with toxoplasmosis
15. Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii IgG, IgE and IgM, and analytical study of specific IgG in immunodeficient patients
16. Secretion of Toxoplasma gondii specific antibodies in vitro by peripheral blood mononuclear cells as a new marker of acute toxoplasmosis
17. Une nouvelle réaction d'agglutination pour le diagnostic du stade évolutif de la toxoplasmose acquise
18. Importance of complete follow-up of spontaneous fetal loss after amniocentesis and chorion villi sampling
19. Randomised controlled trial of genetic amnio-centesis in 4606 low risk-women
20. Preventing congenital toxoplasmosis
21. Polymerase chain reaction for detection of Toxoplasma gondii
22. Detection of Toxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction
23. Direct and sensitive detection of a pathogenic protozoan. Toxoplasma gondii, by polymerase Chain Reaction
24. Use of the polymerase chain reaction to detect Toxoplasma gondii in human blood samples
25. Use of polymerase chain reaction to detect Toxoplasma
26. Detection of the pathogenic parasite Toxoplasma gondii by specific amplification of ribosomal sequences using comultiplex polymerase chain reaction
27. A family of repeated DNA sequences in Toxoplasma gondii: Cloning, sequence analysis, and use in strain characterization
28. Detection of Toxoplasma gondii parasitaemia by polymerase chain reaction in perorally infected mice
29. Microsatellite in the beta-tubulin gene of Toxoplasma gondii as a new genetic marker for use in direct screening of amniotic fluids
30. Use of uracil DNA glycosylase ton control carry-over contamination in polymerase chain reactions
31. Congenital toxoplasmosis: Value of prenatal diagnosis and early postnatal diagnosis. A retrospective study of 110 cases
32. Prenatal diagnosis of congenital toxoplasmosis with a polymerase chain reaction test on amniotic fluid
33. Contribution of a new PCR assay to the prenatal diagnosis of congenital toxoplasmosis
34. Prenatal diagnosis of congenital toxoplamosis in 261 pregnancies
35. Screening for congenital toxoplasmosis: Pregnancy outcome after prenatal diagnosis in 211 cases
36. Antenatal diagnosis of congenital toxoplasmosis: Evaluation of the biological parameters in a cohort of 286 patients
37. Interlaboratory comparison of polymerase chain reaction for the detection of Toxoplasma gondii DNA added to samples of amniotic fluid
38. Quantitation of Toxoplasma gondii DNA in a competitive nested polymerase chain reaction
39. Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR
40. Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogenic stem cell transplantation using fluorescence resonance energy transfer hybridization probes
41. Detection of Toxoplasma gondii in 94 placentae from infected women by polymerase chain reaction, in vivo, and in vitro cultures
42. Congenital toxoplasmosis: Specific IgM in fetal blood, cord blood and in the newborn
43. Lack of value of specific IgA detection in the postnatal diagnosis of congenital toxoplasmosis
44. Performance of a Western blot assay to compare mother and newborn anti-Toxoplasma antibodies for the early neonatal diagnosis of congenital toxoplasmosis
45. Early neonatal diagnosis of congenital toxoplasmosis: Value of comparative enzymelinked immunofiltration assay immunological profiles and anti- Toxoplasma gondii immunoglobulin M or IgA immunocapture and therapeutic strategies
46. Congenital toxoplasmosis: Value of post-natal biological follow-up
47. Control of congenital infection with Toxoplasma gondii by neonatal screening based on detection of specific immunoglobulin M antibodies eluted from phenylketonuria filter-paper blood-spot samples